Elementis Presents Plan to Lift Innovation Sales to 20% of Total in Medium Term

By Public Technologies
  • Elementis plans to increase R&D spending by $6 million, raising it from about 2% to about 3% of sales.
  • Lab upgrades will receive $15 million in capital spending over 2026-2028.
  • Innovation sales are targeted at 20% of total sales in the medium term, up from 16% in 2025.
  • Innovation is expected to generate about one-third of growth, supported by a pipeline that has more than tripled over two years.
  • Medium-term targets include mid-single-digit revenue growth, an adjusted operating margin of at least 23% and cash conversion above 90%.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elementis plc published the original content used to generate this news brief on November 06, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.